When thinking about rTMS and for that matter all Rx in psychiatry pay attention to specific symptoms that are benefited as it’s more meaningful. These data support my impression of pro-cognitive effects in persons with depression https://t.co/39SsP76SbK
New #depression#psiloybin has 2 severe issues.
(1) They don't adhere to their protocol registered on https://t.co/A7kt87eQfa & report primary outcomes at week 2, when week 4 was registered. I'm so frustrated that scientists (but also reviewers & editors) don't do their job.
Na minha coluna no @NexoJornal de hoje, falo de como a pós-graduação virou um esquema de “pirâmide acadêmica” no Brasil e no mundo, e sobre formas de lidar com isso: https://t.co/MzLx16D6op